Ossiam’s TG Therapeutics TGTX Stock Holding History

Ossiam’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-279,305	Closed	-$4.77M	–	681
2023 Q4	$4.77M	Hold	279,305	–	–	0.08%	126
2023 Q3	$2.33M	Hold	279,305	–	–	0.04%	187
2023 Q2	$6.94M	Buy	+279,305	New	+$7.21M	0.12%	117

Other funds holding TGTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ossiam's TGTX Position: Q1 2024 in Review

Ossiam sold out of TG Therapeutics (TGTX) in Q1 2024, closing a stake of 279,305 shares — an estimated $4.77M sold.

Ossiam first reported a position in TGTX in Q2 2023 and held it in 3 quarters. The position peaked at $6.94M in Q2 2023. 243 funds tracked by Wall St. Rank hold TGTX as of Q1 2024.

Ossiam reported no remaining TG Therapeutics position as of Q1 2024 after selling out during the quarter.
Ossiam sold 279,305 TG Therapeutics shares in Q1 2024, an estimated $4.77M.
Ossiam first reported a position in TG Therapeutics in Q2 2023 and held it in 3 quarters.
Ossiam's TG Therapeutics position peaked at $6.94M in Q2 2023.
243 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2024.

Based on Ossiam's 13F filing for Q1 2024, filed 13 May 2024.